• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

["明斯特前瞻性心血管病"研究结果]

[Results of the "Munster Prospective Cardiovascular" study].

作者信息

Schulte H, Assmann G

机构信息

Institut für Arterioskleroseforschung, Universität Münster.

出版信息

Soz Praventivmed. 1988;33(1):32-6. doi: 10.1007/BF02084003.

DOI:10.1007/BF02084003
PMID:3259765
Abstract

In the 'Prospective Cardiovascular Münster' (PROCAM) study since 1979 employees have been examined for cardiovascular risk factors and held under observation for the onset of clinically significant signs of atherosclerosis (myocardial infarction, stroke, coronary death). Until the end of recruitment (end of 1985) 20,060 male and female employees aged 17-65 from 52 industrial companies in Westfalia have participated. The voluntary examination at the start of the observation period includes a standardised questionnaire, a physical examination, blood pressure measurements and an ECG. Blood samples are taken after an overnight fast. The data presented here describe the longitudinal evaluation of initially healthy men aged 40 to 65 who had suffered no myocardial infarction or stroke before the examination. In an uniform follow-up period of four years 73 myocardial infarctions and coronary deaths were observed while 2681 men had survived without myocardial infarction or stroke. By far the best single parameter for establishing a risk group was HDL cholesterol. Using the characteristic hyper/dyslipoproteinemia which means cholesterol greater than = 300 mg/dl or HDL cholesterol less than 35 mg/dl combined with cholesterol greater than = 200 mg/dl and/or triglyceride greater than = 200 mg/dl or a multiple logistic function including age, cholesterol, HDL cholesterol, systolic blood pressure, cigarette smoking, diabetes mellitus, angina pectoris and a family history of myocardial infarction patients at high risk for coronary heart disease could be identified. More than two thirds of new events happened in each of these high risk subgroups, which comprise less than 20 percent of men under consideration each.

摘要

自1979年起开展的“明斯特心血管病前瞻性研究”(PROCAM)中,对员工进行了心血管危险因素检查,并对动脉粥样硬化临床显著体征(心肌梗死、中风、冠状动脉性死亡)的发生情况进行观察。截至招募结束(1985年底),来自威斯特法伦州52家工业公司的20060名年龄在17至65岁之间的男女员工参与了研究。观察期开始时的自愿检查包括标准化问卷、体格检查、血压测量和心电图检查。在禁食过夜后采集血样。此处呈现的数据描述了对40至65岁、检查前未发生过心肌梗死或中风的初发健康男性的纵向评估。在四年的统一随访期内,观察到73例心肌梗死和冠状动脉性死亡,而2681名男性未发生心肌梗死或中风存活下来。到目前为止,用于建立风险组的最佳单一参数是高密度脂蛋白胆固醇。利用特征性的高/血脂蛋白血症,即胆固醇≥300mg/dl或高密度脂蛋白胆固醇<35mg/dl,同时胆固醇≥200mg/dl和/或甘油三酯≥200mg/dl,或者使用包含年龄、胆固醇、高密度脂蛋白胆固醇、收缩压、吸烟、糖尿病、心绞痛以及心肌梗死家族史的多元逻辑函数,可以识别出冠心病高危患者。这些高危亚组中每组发生的新事件超过三分之二,而每个亚组所包含的男性在研究对象中均不到20%。

相似文献

1
[Results of the "Munster Prospective Cardiovascular" study].["明斯特前瞻性心血管病"研究结果]
Soz Praventivmed. 1988;33(1):32-6. doi: 10.1007/BF02084003.
2
The Prospective Cardiovascular Münster Study: prevalence and prognostic significance of hyperlipidemia in men with systemic hypertension.
Am J Cardiol. 1987 May 29;59(14):9G-17G. doi: 10.1016/0002-9149(87)90152-4.
3
The Münster Heart Study (PROCAM). Results of follow-up at 8 years.明斯特心脏研究(PROCAM)。8年随访结果。
Eur Heart J. 1998 Feb;19 Suppl A:A2-11.
4
Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk.脂蛋白(a)会进一步增加全球心血管风险高的男性发生冠状动脉事件的风险。
J Am Coll Cardiol. 2001 Feb;37(2):434-9. doi: 10.1016/s0735-1097(00)01126-8.
5
New and classical risk factors--the Münster heart study (PROCAM).新的和传统的危险因素——明斯特心脏研究(PROCAM)。
Eur J Med Res. 1997 Jun 16;2(6):237-42.
6
Assessing risk of myocardial infarction and stroke: new data from the Prospective Cardiovascular Münster (PROCAM) study.评估心肌梗死和中风风险:来自明斯特前瞻性心血管研究(PROCAM)的新数据。
Eur J Clin Invest. 2007 Dec;37(12):925-32. doi: 10.1111/j.1365-2362.2007.01888.x.
7
Hemostatic variables in the prediction of coronary risk: results of the 8 year follow-up of healthy men in the Münster Heart Study (PROCAM). Prospective Cardiovascular Münster Study.止血变量在预测冠心病风险中的作用:明斯特心脏研究(PROCAM)中健康男性8年随访结果。明斯特前瞻性心血管研究。
Isr J Med Sci. 1996 Jun;32(6):364-70.
8
The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers.明斯特心脏研究(PROCAM):在吸烟者中,总胆固醇和低密度脂蛋白胆固醇浓度较低时中年男性的全因死亡率会升高,但在不吸烟者中并非如此。
Circulation. 1997 Oct 7;96(7):2128-36. doi: 10.1161/01.cir.96.7.2128.
9
Type 2 diabetes mellitus and risk of coronary heart disease: results of the 10-year follow-up of the PROCAM study.2型糖尿病与冠心病风险:PROCAM研究10年随访结果
Eur J Cardiovasc Prev Rehabil. 2007 Apr;14(2):230-6. doi: 10.1097/HJR.0b013e3280142037.
10
Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study.高密度脂蛋白胆固醇和甘油三酯与动脉粥样硬化性冠状动脉疾病发病率的关系(PROCAM研究经验)。明斯特前瞻性心血管研究。
Am J Cardiol. 1992 Sep 15;70(7):733-7. doi: 10.1016/0002-9149(92)90550-i.

引用本文的文献

1
The association between the body height and cardiovascular diseases: a retrospective analysis of 657,310 outpatients in Germany.身高与心血管疾病的相关性:德国 657310 名门诊患者的回顾性分析。
Eur J Med Res. 2022 Nov 9;27(1):240. doi: 10.1186/s40001-022-00881-y.

本文引用的文献

1
Multifactorial trial in the prevention of coronary heart disease: 1. Recruitment and initial findings. World Health Organization European Collaborative group.预防冠心病的多因素试验:1. 招募与初步结果。世界卫生组织欧洲协作组
Eur Heart J. 1980 Feb;1(1):73-80.
2
[Prediction and early diagnosis of coronary disease. Prospective epidemiologic study of industrial workers in Westphalia].
Internist (Berl). 1980 Aug;21(8):446-59.
3
Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.无需使用制备性超速离心机来估算血浆中低密度脂蛋白胆固醇的浓度。
Clin Chem. 1972 Jun;18(6):499-502.
4
Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.冠心病预防策略:欧洲动脉粥样硬化学会政策声明
Eur Heart J. 1987 Jan;8(1):77-88.
5
Multivariate prediction of coronary heart disease in the Western Collaborative Group Study compared to the findings of the Framingham study.
Circulation. 1976 Feb;53(2):348-55. doi: 10.1161/01.cir.53.2.348.